Compare CVS Health Corp (CVS) vs Invesco Solar ETF (TAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Invesco Solar ETF — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.29B), while Invesco Solar ETF trades at $44.02 (market cap $894.08M). The key difference: CVS Health Corp is far larger — about 125.6× Invesco Solar ETF's market cap, and CVS Health Corp pays a 3.03% dividend while Invesco Solar ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Invesco Solar ETF for 34 Days on average.
| CVS | TAN | |
|---|---|---|
Market Cap | $112.29B | $894.08M |
Volume | 7,763,676 | 370,994 |
Sector | Health | Sector/Thematic |
52-Week High | $110.60 | $73.95 |
52-Week Low | $70.08 | $43.00 |
Typical Hold Time | 83 Days | 34 Days |
Enterprise Value | $174.64B | — |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
TAN (Invesco Solar ETF) trades at $43.53, down 1.96% amid sector-wide pressure from high borrowing costs impacting solar project financing. Technical indicators show a bearish trend with strong sell signals from moving averages, while oscillators remain neutral. Recent news highlights solar stocks facing headwinds from interest rate sensitivity and market saturation concerns, though long-term growth drivers from energy transition remain intact.
The ETF faces near-term challenges from financing costs and competitive pressures, but maintains strategic positioning in the growing solar energy sector. Investors should weigh volatility risks against potential policy tailwinds and increasing global renewable energy adoption for long-term growth opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Invesco Solar ETF
TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →
